Login / Signup

European Medicines Agency seeks stakeholders' views on future transparency measures for clinical trials.

Rosa Gonzalez-QuevedoLaura PioppoJuan Garcia BurgosPeter Arlett
Published in: British journal of clinical pharmacology (2023)
Keyphrases
  • clinical trial
  • current status
  • phase ii
  • open label
  • drug administration
  • phase iii
  • double blind
  • study protocol
  • randomized controlled trial